The Imperial College London and The George Institute for Global Health will continue their 2020 collaboration over a further five years to drive development and evaluation of innovative and sustainable global health systems. The large-scale, transformative research initiatives will focus on health systems, women's health and multimorbidity which were highlighted as some of the greatest global health challenges. Professorial-level appointments for each area will follow. | https://sciencebusiness.net/network-updates/imperial-and-george-institute-renew-collaboration-drive-health-innovation
An eye drop that improves close-range vision could make misplaced reading glasses less of an inconvenience. Vuity, which has became available by prescription, is a once-a-day treatment that can help users see up close without affecting their long-range vision.Vuity’s benefit over reading glasses is that it does not impair distance vision as reading glasses do. Usually, when a person stops reading to do something else, they need to remove their reading glasses to see around them properly.https://inkl.com/a/ZYvJaVTwlE
A Tel Aviv University study found that a drug that was designated as an “orphan drug” by the FDA – meaning it is used to treat rare diseases and is subject to separate regulations – can also treat a variety of symptoms associated with autism, intellectual disabilities, and Alzheimer’s disease. “This study is an important milestone on the way to developing a drug, or drugs, that will help children with autism stemming from genetic mutations, as well as Alzheimer’s patients,” Grozes concluded. Read the full article on the Israel Trade and Economic Commission's Website: https://israeltrade.org.au/2021/12/09/drug-for-rare-disease-effective-for-alzheimers-autism-treatment/
